Cutia Therapeutics

SEHK:2487 Voorraadrapport

Marktkapitalisatie: HK$3.5b

Cutia Therapeutics Balans Gezondheid

Financiële gezondheid criteriumcontroles 4/6

Cutia Therapeutics has a total shareholder equity of CN¥1.2B and total debt of CN¥210.3M, which brings its debt-to-equity ratio to 17.7%. Its total assets and total liabilities are CN¥1.5B and CN¥319.4M respectively.

Belangrijke informatie

17.7%

Verhouding schuld/eigen vermogen

CN¥210.33m

Schuld

Rente dekkingsration/a
ContantCN¥1.04b
AandelenCN¥1.19b
Totaal verplichtingenCN¥319.44m
Totaal activaCN¥1.51b

Recente financiële gezondheidsupdates

Recent updates

Does Cutia Therapeutics (HKG:2487) Have A Healthy Balance Sheet?

Aug 30
Does Cutia Therapeutics (HKG:2487) Have A Healthy Balance Sheet?

A Look At The Intrinsic Value Of Cutia Therapeutics (HKG:2487)

Jun 03
A Look At The Intrinsic Value Of Cutia Therapeutics (HKG:2487)

Analysts Are Betting On Cutia Therapeutics (HKG:2487) With A Big Upgrade This Week

Apr 08
Analysts Are Betting On Cutia Therapeutics (HKG:2487) With A Big Upgrade This Week

Analyse van de financiële positie

Kortlopende schulden: 2487's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥237.8M).

Langlopende schulden: 2487's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥81.7M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 2487 has more cash than its total debt.

Schuld verminderen: Insufficient data to determine if 2487's debt to equity ratio has reduced over the past 5 years.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: 2487 has sufficient cash runway for more than a year based on its current free cash flow.

Voorspelling contante baan: Insufficient data to determine if 2487 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Ontdek gezonde bedrijven